戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PPA at 2 mM decreased neurite outgrowth to (80.70 um +/-
2                                              PPA imprinted polymers bound PPA with an equilibrium con
3                                              PPA provides a novel perspective that uniquely addresses
4                                              PPA was 92.8%, 84.9%, 93.0%, 100%, and 95.6%, for norovi
5 o-collect nasal swabs but demonstrated <100% PPA compared to PCR.
6       Patients diagnosed with bvFTD (n=124), PPA (n=34) and CBS (n=85) were recruited.
7 ligand as a photosensitizer and Co(dmgH)(2) (PPA)Cl (PPA-Co, dmgH=dimethylglyoxime; PPA=4-pyridinepro
8                  We prospectively studied 25 PPA and 21 healthy individuals who underwent extensive c
9 al amyloid (Abeta(+) ) was found in 19 of 32 PPA patients.
10 5% confidence interval [CI], 75.3 to 90.6%), PPA was 68.0% (95% CI, 53.3 to 80.5%), and the kappa coe
11                        The PPA-FTLD (n = 6), PPA-AD (n = 7), and AMN-AD (n = 6) groups did not differ
12                                            A PPA describes the steps that people with tuberculosis ta
13 This paper summarizes the steps to conduct a PPA and serves as the basis for understanding country ca
14           Contrived specimens demonstrated a PPA between 95 and 100% and an NPA of 100% for all targe
15                             The results of a PPA reveal programmatic gaps in care seeking, diagnosis,
16 CR reference method threshold cutoff, were a PPA of 62.1% (72 of 116 results; 95% CI, 52.6%-70.9%) an
17                           The targets with a PPA of <100% were Staphylococcus aureus (34/37 [91.9%]),
18 than 97.0%, except Ehrlichia ewingii, with a PPA of 88.9%.
19 amyloid burden was compared between Abeta(+) PPA and an Abeta(+) amnestic dementia groups (n = 22).
20 cluded 7-day point prevalence of abstinence (PPA) and level of readiness to quit at each follow-up.
21 mono- or dianions of phenyl phosphonic acid (PPA), phenyl sulfonic acid (PSA), and benzoic acid (BA)
22 aired production of phosphopantothenic acid (PPA) from vitamin B5.
23 e entrapped in chitosan-polyphosphoric acid (PPA) beads.
24 graphene/graphite) in a polyphosphoric acid (PPA)/phosphorous pentoxide (P2 O5 ) medium are elucidate
25 e investigated the effect of Propionic acid (PPA), a short-chain fatty acid (SCFA) and a product of d
26 aging (DTI) metrics to assess changes across PPA variants and perform brain-behavioral correlations.
27 an autopsy-confirmed diagnosis of either AD (PPA-AD) or a tau variant of FTLD (PPA-FTLD) and 6 patien
28                            The P. aeruginosa PPA and NPA, respectively, were 95.9% (88.6%, 98.6%) and
29 itive and negative percentages of agreement (PPA and NPA, respectively) between CPO detect and the RM
30 nstrated a positive percentage of agreement (PPA) between 60 and 100% for four targets (blaKPC, blaND
31 d a positive and negative percent agreement (PPA and NPA, respectively) between the Aries and Xpert a
32 all positive and negative percent agreement (PPA and NPA, respectively) of the cobas Cdiff assay comp
33 ence method, the positive percent agreement (PPA) (95% confidence interval [CI]), negative percent ag
34              The positive percent agreement (PPA) among the microbial targets was 96.5%, and the nega
35 a combined 96.2% positive percent agreement (PPA) and 98.1% negative percent agreement (NPA) for the
36              The positive percent agreement (PPA) and negative percent agreement (NPA) between the TP
37 ays, the overall positive percent agreement (PPA) and negative percent agreement (NPA) for B. pertuss
38              The positive percent agreement (PPA) and negative percent agreement (NPA) for MCR-1 dete
39 occus pyogenes), positive percent agreement (PPA) and negative percent agreement (NPA) ranged from 93
40 ture or EIA, the positive percent agreement (PPA) and negative percent agreement (NPA) values for the
41 rus assay showed positive percent agreement (PPA) and negative percent agreement (NPA) values of 98.3
42                  Positive percent agreement (PPA) and negative percent agreement (NPA) were calculate
43 aluated included positive percent agreement (PPA) and negative percent agreement (NPA) with the ARUP
44 aluated included positive percent agreement (PPA) and negative percent agreement (NPA) with the FilmA
45 udy, the overall positive percent agreement (PPA) and the overall negative percent agreement (NPA) of
46 also had highest positive percent agreement (PPA) compared to our reference standard (98.3%) followed
47 ire assays had a positive percent agreement (PPA) of 98.7%, followed by the Aptima assay at 94.7%, co
48 al cultures, the positive percent agreement (PPA) of the BC-GN assay with the reference method was as
49 rcent agreement, positive percent agreement (PPA), negative percent agreement (NPA), and Cohen's kapp
50 ve, negative, and overall percent agreement (PPA, NPA, and OPA, respectively) were the primary outcom
51 emonstrated a positive percentage agreement (PPA) of 91.1% (195 of 214 results; 95% confidence interv
52    Positive and negative percent agreements (PPA and NPA, respectively) between the assays were calcu
53 and self-rectal positive percent agreements (PPA) for NG detection were 92.8% and 97.6%; clinician-re
54                 Positive percent agreements (PPAs) and negative percent agreements (NPAs) of the PLEX
55 ing for renewable power purchase agreements (PPAs), displaced generation and capacity costs, and net
56 tanding cleft sentence structures, while all PPA variants and patients with bvFTD were impaired with
57 cterization of prephenate aminotransferases (PPA-ATs) that belong to class-Ib aspartate aminotransfer
58  (HSA) and Porcine Pancreatic alpha-amylase (PPA).
59 K PEGylated-Pancreatic Polypeptide analogue (PPA) and 20K PEGylated-glucagon, we elucidated the decom
60 ional and regional patient pathway analyses (PPAs) were undertaken using existing national survey and
61                The patient-pathway analysis (PPA) is designed to assess the alignment between tubercu
62                The patient-pathway analysis (PPA) methodology detailed in this article was developed
63                  A patient-pathway analysis (PPA) was completed to assess the alignment between patie
64                  A patient-pathway analysis (PPA) was conducted at the national level, as well as for
65                  A patient pathway analysis (PPA) was conducted to assess the alignment between patie
66               Following discrepant analysis, PPA and NPA values were as follows: 97.3% and 99.8% for
67 tudy of disease genes identified in 2012 and PPA data produced before that date.
68 pped with triflate as strong Lewis acids and PPA-Co as a hydrogen transfer catalyst.
69 ncremental utility at low DB levels (CBS and PPA) and were associated with overlapping and distinct n
70 odalities were useful in identifying CBS and PPA, whereas DB alone was useful for identifying bvFTD.
71 tions with specialized areas such as FFA and PPA.
72 n time whereas maximum inhibition of HSA and PPA by EC was reached only after 45 to 60 min of incubat
73   EGCG reached maximum inhibition of HSA and PPA with short incubation time whereas maximum inhibitio
74 cy-related components were found for PSA and PPA.
75 ive tasks across the full spectra of PSA and PPA.
76 ; 95% confidence interval, significance) and PPA progression (1.7; 1.2-2.4, P = .002).
77 nd for T2, increases were seen at the SZ and PPA only.
78 mentia (bvFTD), primary progressive aphasia (PPA) and corticobasal syndrome (CBS).
79 tia syndrome of primary progressive aphasia (PPA) can be caused by 1 of several neuropathologic entit
80                 Primary progressive aphasia (PPA) is a clinical syndrome characterised by progressive
81                 Primary progressive aphasia (PPA) is a progressive language disorder associated with
82  stimulation in primary progressive aphasia (PPA) is a promising approach.
83                 Primary progressive aphasia (PPA) refers to a disorder of declining language associat
84 f patients with primary progressive aphasia (PPA) variants defined by current diagnostic classificati
85 tic variants of primary progressive aphasia (PPA), progressive supranuclear palsy and corticobasal sy
86              In primary progressive aphasia (PPA), speech and language difficulties are caused by neu
87 f deposition in primary progressive aphasia (PPA).
88 ften damaged in primary progressive aphasia (PPA).
89 rodegeneration (primary progressive aphasia, PPA) have overlapping symptomatology, nomenclature and a
90 interest (ROIs): parahippocampal place area (PPA) and lateral occipital complex (LOC).
91 al connection to parahippocampal place area (PPA) compared with adjacent regions (e.g., fusiform face
92  argued that the parahippocampal place area (PPA) represents such navigationally relevant information
93 For example, the parahippocampal place area (PPA) responds maximally to environmental scenes during f
94 we show that the parahippocampal place area (PPA), a region in human occipitotemporal cortex, exhibit
95 e area (FFA) and parahippocampal place area (PPA), respectively.
96 eriorly from the parahippocampal place area (PPA), retrosplenial complex (RSC) and occipital place ar
97  patterns in the parahippocampal place area (PPA), retrosplenial complex (RSC), and occipital place a
98  processing: the parahippocampal place area (PPA), the retrosplenial complex (RSC), and a region arou
99 responses in the parahippocampal place area (PPA), transverse occipital sulcus, and retrosplenial cor
100 stimuli, and the parahippocampal place area (PPA), which showed better texture than layout decoding.
101 omplex (RSC) and parahippocampal place area (PPA).
102  response within parahippocampal place area (PPA).
103 s, including the parahippocampal place area (PPA).
104 e MTL, mPFC, and Parahippocampal Place Area (PPA).
105 ubpistonal area [SPA] and peripistonal area [PPA]) were defined as regions of interest.
106   This area (the parahippocampal place area [PPA]) was initially interpreted as responding selectivel
107 rtical area (the parahippocampal place area; PPA) showed distinctively higher functional magnetic res
108  Artery [SFA] and Proximal Popliteal Artery [PPA] [INPACT SFA II], NCT01566461; MDT-2113 Drug-Eluting
109 tery [SFA] and/or Proximal Popliteal Artery [PPA]) that enrolled 331 subjects with symptomatic (Ruthe
110 ere, we analyze protein-protein association (PPA) networks to identify candidate genes in the vicinit
111 ession (kappa = 0.7), parapapillary atrophy (PPA) progression (kappa = 0.7), disc hemorrhages (kappa
112 d for the presence of peripapillary atrophy (PPA), peripapillary pigment (PPP), drusen in the macula,
113 y (DOT) using preprescription authorization (PPA) vs postprescription review with feedback (PPRF) str
114                             The A. baumannii PPA and NPA, respectively, were 97.1% (90.2%, 99.2%) and
115                 PPA imprinted polymers bound PPA with an equilibrium constant K(eq) = 1.8 x 10(5) M(-
116                       Restoration of central PPA levels by delivery of exogenous PPA is a recent stra
117 verall, these results indicate that chitosan-PPA beads show potential for lower gastrointestinal deli
118 entrapment of the proteins in these chitosan-PPA beads.
119 s a photosensitizer and Co(dmgH)(2) (PPA)Cl (PPA-Co, dmgH=dimethylglyoxime; PPA=4-pyridinepropionic a
120                 Among patients with clinical PPA syndrome, AD neuropathology appeared to interfere wi
121 uasi-experimental, crossover trial comparing PPA and PPRF for adult inpatients prescribed any antibio
122                                      Current PPA criteria divide PPA into three variants: non-fluent
123 iated by boron trifluoride results in cyclic PPA in high yield, with high molecular weight, and with
124  end groups enhances the stability of cyclic PPA and makes it an attractive candidate for lithographi
125 ing to PPA's low ceiling temperature, cyclic PPA is capable of chain extension to larger molecular we
126 t groups also differed in the rates of 7-day PPA (24.6% versus 17.4%, P = 0.02).
127 eo and text groups had higher rates of 7-day PPA than the control group at 6 months (video group: 24.
128 ial of this new class of prodrugs to deliver PPA to the brain following oral administration and confi
129 onfirms incorporation of the prodrug-derived PPA into CoA.
130                In contrast, the differential PPA response to buildings versus nonbuildings occurred l
131 )(2) (PPA)Cl (PPA-Co, dmgH=dimethylglyoxime; PPA=4-pyridinepropionic acid) on the Hf(12) secondary bu
132 the single MR modality models to distinguish PPA variants (accuracy was 0.86, 0.73, and 0.68 for the
133                  Current PPA criteria divide PPA into three variants: non-fluent (nfvPPA), semantic (
134                         INTERPRETATION: Each PPA clinical variant is associated with a typical and mo
135 rns, we identified ICNs associated with each PPA variant.
136      A subset of AspAT Ib enzymes exhibiting PPA-AT activity was further identified from both Plantae
137  central PPA levels by delivery of exogenous PPA is a recent strategy to reactivate CoA biosynthesis
138   Following discrepant resolution, the final PPA and NPA for the TBP panel were 97.7% (95% confidence
139 logopenic PPA and those who met criteria for PPA but not a specific subtype.
140  imply a causal role in scene processing for PPA and RSC, no such evidence exists for OPA.
141 ly, the data supports a significant role for PPA in modulating hNSC patterning leading to gliosis, di
142  nonpreferred category of an ROI (scenes for PPA, objects for LOC).
143 vFTD from CBS patients and 93% of bvFTD from PPA patients-30% and 13% above base rates (59%, 80%), re
144 either AD (PPA-AD) or a tau variant of FTLD (PPA-FTLD) and 6 patients who had the clinical diagnosis
145                             Likewise, GPR41 (PPA receptor) and pro-survival p-Akt protein were elevat
146                      In study 2, Veritor had PPA, NPA, and OPA values of 97.4, 98.1, and 98.1%, respe
147  characterization, the PLEX-ID Flu assay had PPAs and NPAs of 98.3% and 97.5% for H1N1-p, 88.6% and 1
148                                           In PPA, FTLD-TDP and FTLD-Tau have divergent anatomic distr
149 o results and showed a slight improvement in PPA over ID NOW.
150  lateralized pattern of neurodegeneration in PPA.
151 ve antemortem diagnosis of neuropathology in PPA.
152 nd has rarely been performed in health or in PPA.
153  the preference for cardinal orientations in PPA, thus demonstrating that the oblique effect can also
154 t the oblique effect can also be produced in PPA by simple geometrical images, with statistics simila
155 ng block for category-selective responses in PPA and functionally related areas.
156            All tested targets had an initial PPA greater than 97.0%, except Ehrlichia ewingii, with a
157              Moreover, mPFC exhibited larger PPA-connectivity for more congruent associations.
158 bjects and increases BOLD signal in the left PPA when viewing scenes.
159       Simulated successional patterns by LM3-PPA from the leaf physiological trade-offs are consisten
160 al-based dynamic vegetation model (i.e., LM3-PPA).
161 onfluent/agrammatic, semantic, and logopenic PPA variants.
162          We included patients with logopenic PPA and those who met criteria for PPA but not a specifi
163 rly individuals living in nursing homes, low PPA from central to peripheral arteries strongly predict
164 , in both SGF and SIF, was achieved with low PPA concentration.
165 rium acnes, Lactobacillus, and Micrococcus), PPA and NPA ranged from 84.5% to 100% and 99.9% to 100%,
166  (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA.
167 eased to (0.42 ug/ul +/- 0.04 ug/ul) at 2 mM PPA compared to (0.83 ug/ul +/- 0.09 ug/ul) in control (
168                               Following 2 mM PPA exposure, TNF-alpha transcription increased 4.98 fol
169 this review, I discuss linguistic aspects of PPA syndromes that may prove informative for parsing our
170 ing and memory in autopsy-confirmed cases of PPA.
171                        The classification of PPA into one of the three variants may be performed at 3
172                      In an autopsy cohort of PPA (FTLD-TDP = 13, FTLD-Tau = 14), we analyzed laterali
173 ts who had the primary clinical diagnosis of PPA and an autopsy-confirmed diagnosis of either AD (PPA
174               Imaging-supported diagnosis of PPA variant is more feasible with quantitative analysis
175                      A clinical diagnosis of PPA was associated with frontotemporal lobar degeneratio
176 lity of the imaging-supported diagnostics of PPA variants in the Polish clinical setting with access
177 , the subtle learning and memory features of PPA and their neuropathologic associations have not been
178 ng (SPECT, albeit not MRI), thus level II of PPA diagnosis could be established in those cases.
179                              Irrespective of PPA syndromic variant, single-word comprehension impairm
180 o new series of cyclic phosphate prodrugs of PPA capable of regenerating excellent levels of CoA in t
181 iations within and between other subtypes of PPA and PSA.
182 y categorical boundaries for any subtypes of PPA or PSA.
183 country case studies that profile the use of PPA.
184                                  Variants of PPA are important to recognize from a medical perspectiv
185                                Two series of PPAs substituted at the phenyl ring in ortho, meta, and
186 t of candidates together with information on PPAs, frequency and predicted pathogenicity of the varia
187                                The optimized PPA/P2 O5 medium is a mild acid that is not only less co
188 ior frontal junction, IFJ, and either FFA or PPA, depending on which object was attended.
189  advanced by 20 ms in IFJ compared to FFA or PPA.
190 , which were not observed in the PPA-FTLD or PPA-AD groups (all P < .005).
191                 Fosmetpantotenate is an oral PPA prodrug.
192 ulty with centre-embedded sentences in other PPA variants was related to other brain regions.
193 he EDTA-CBDE screening method had an overall PPA and NPA of 100% and 94.3%, respectively.
194 ma assay showed a modest decrease in overall PPA.
195                                  The overall PPA and NPA for B. parapertussis were 96.7% and 100%, re
196  retrospective frozen specimens, the overall PPA and NPA for both targets were 92.6% and 93.2%, respe
197 For prospective fresh specimens, the overall PPA and NPA for both targets were 97.7% and 99.3%, respe
198             End-capped poly(phthalaldehyde) (PPA) synthesized by anionic polymerization has garnered
199                                        Plant PPA-ATs and succeeding arogenate dehydratases (ADTs) wer
200  and (46.63% +/- 2.5%) glia (GFAP positive), PPA treatment drastically shifted differentiation to 80%
201 phere diameter also increased at day 10 post PPA treatment to (Mean: 193.47 um +/- SEM: 6.673 um) ver
202 alternative ionic polymerizations to produce PPA have been largely unexplored.
203 esting for the 0 to 5 and 0 to 6 DSO ranges (PPA values of 83.9% and 82.4%, respectively).
204 and 97.6%; clinician-rectal, and self-rectal PPA for CT detection were 95.6% and 97.2%.
205  observed in helical poly(phenylacetylene)s (PPAs) when either the type of linkage with the pendant g
206 ion index was estimated for scene-selective (PPA) and object-selective (LOC) cortical regions while p
207 t current stimulation (tDCS) on the semantic PPA variant (sv-PPA), applying a rigorous study design t
208 Syphilis IgG immunoassay displayed a similar PPA (100%) but a substantially lower NPA (15.9%).
209 ith ADT, a gene encoding prephenate-specific PPA-AT was transferred from a Chlorobi/Bacteroidetes anc
210 ere collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfv
211          For its part, the ortho-substituted PPA (o-poly-1) presents a highly stretched, almost plana
212                             Meta-substituted PPAs (m-poly-1 and m-poly-2) exist as a mixture in equil
213                                Surprisingly, PPA and PSA have rarely been directly compared in detail
214 itions targeting the temporal poles of 12 sv-PPA patients.
215 rous study design to a large, homogeneous sv-PPA cohort.
216  predominantly left-lateralized damage in sv-PPA and accounts of interhemispheric inhibition, we appl
217 ngs demonstrate the efficiency of tDCS in sv-PPA by generating highly specific intrasemantic effects.
218 ation (tDCS) on the semantic PPA variant (sv-PPA), applying a rigorous study design to a large, homog
219                       The Chlorobium tepidum PPA-AT and ADT homologs indeed efficiently converted pre
220                                We found that PPA was consistently activated by rectilinear features,
221                   Here, we hypothesized that PPA responds selectively to a lower-level stimulus prope
222                         We hypothesized that PPA responses to scenes and buildings might be driven by
223    However, subsequent studies reported that PPA also responds strongly to a much wider range of imag
224                                          The PPA and NPA between the Aries and BD Max assays were 91.
225                                          The PPA and NPA between the manual and BioPlex 2200 RPR resu
226                                          The PPA and NPA for Enterobacterales were 98.5% (confidence
227                                          The PPA assessed the alignment between patient care seeking
228                                          The PPA can help programs understand where they might find t
229                                          The PPA differentiation index also predicted performance on
230                                          The PPA for identification of resistance determinants was as
231                                          The PPA for the manual RPR-positive population was 88% (88/1
232                                          The PPA identified opportunities for strengthening access to
233                                          The PPA results emphasize the role that the private sector p
234                                          The PPA results revealed that only 20% of patients encounter
235                                          The PPA values for carbapenemase class designations for all
236                                          The PPA-FTLD (n = 6), PPA-AD (n = 7), and AMN-AD (n = 6) gro
237                                          The PPA-FTLD group had normal (ie, near-ceiling) scores on a
238                              In study 1, the PPA for Veritor, compared to Lyra, ranged from 81.8 to 8
239 pectrum of functional groups accessible, the PPA/P2 O5 -driven Friedel-Crafts acylation offers more o
240                            Additionally, the PPA differentiation index predicted recognition memory p
241 rovide further evidence that V1, RSC and the PPA not only contain information relevant for natural sc
242  regions of human visual cortex, such as the PPA, has been linked to the semantic and categorical pro
243                                     Both the PPA-AD and AMN-AD groups had deficits in verbal effortle
244                              Discussion: The PPA can be a valuable planning and programming tool to e
245                              Discussion: The PPA results emphasized the need for a differentiated app
246 Age-related reductions were observed for the PPA, but not for the LOC, differentiation index.
247                              Instead, if the PPA represents general category information (as hypothes
248                                       If the PPA represents landmark information, then it must be abl
249                             Importantly, the PPA differentiation index demonstrated age-invariant cor
250                   Median patient DOTs in the PPA and PPRF arms were 8 and 6 DOT per 1000 PD, respecti
251 ic DOTs remained relatively unchanged in the PPA arm.
252 nowing the correspondences among them in the PPA but not in the other two regions, suggesting that th
253 neural response to different clusters in the PPA could be predicted by the similarity in their image
254 % and 41% of patients on days 1 and 3 in the PPA group (P < .01) and in 57% and 36% of patients on da
255 eater left lateralized amyloid uptake in the PPA group than the amnestic group (p < 0.007), consisten
256    Interestingly, the neural response in the PPA was also predicted by perceptual responses to the sc
257             The differentiation index in the PPA, but not the LOC, was lower in older than in younger
258  accuracy for good than bad exemplars in the PPA, RSC and V1.
259  8.33 [5.2]), which were not observed in the PPA-FTLD or PPA-AD groups (all P < .005).
260  distinct patterns of neural response in the PPA.
261 nd navigating our environment, including the PPA and RSC, respectively.
262 d the observation that lesions involving the PPA cause topographic disorientation, there is little ca
263   Our results support the causal role of the PPA in the perception of visual scenes, demonstrate that
264 levant for the differential diagnosis of the PPA variants in clinical practice.
265 no samples positive for B. parapertussis The PPA and NPA of the Aries BA were 61.1% (95% confidence i
266                            Specifically, the PPA treats different perceptual instantiations of the sa
267                            We found that the PPA distinguished scene from nonscene stimuli in approxi
268 n the other two regions, suggesting that the PPA is the key region involved in learning the different
269                 Here we hypothesize that the PPA is, in fact, not well suited to recognize specific l
270 son study at the fourth site showed that the PPA ranged from 98.9% to 100% and that the NPA ranged fr
271              As predicted, we found that the PPA represents 2 buildings from the same category, but i
272  were 2686 and 2693 patients admitted to the PPA and PPRF groups, with 29% and 27% of patients prescr
273 onths, 2 medicine teams were assigned to the PPA arm and the other 2 teams to the PPRF arm.
274 D) but remained constant when changed to the PPA arm.
275 o scenes compared with faces, similar to the PPA.
276                                          The PPAs for resistance markers were as follows: mecA, 97.2%
277    This analysis aggregates and compares the PPAs from case studies in Kenya, Ethiopia, Indonesia, th
278                           When comparing the PPAs of cobas Cdiff and Xpert C. difficile with culture,
279                                        Thus, PPA shows distinctive fMRI selectivity for cardinal orie
280 ofile and an atypical functional coupling to PPA compared with human controls.
281 liferated to 66 neuropsheres when exposed to PPA versus 45 in control.
282                                     Owing to PPA's low ceiling temperature, cyclic PPA is capable of
283 at the best markers to differentiate the two PPA variants at an individual patient level among cortic
284 a discussion of nonfluent/agrammatic variant PPA, the supporting role of short-term memory in a discu
285 al variant FTD (bvFTD), 7 non-fluent variant PPA (nfvPPA), 6 semantic variant PPA (svPPA) and 25 pati
286 pairments consistent with non-fluent variant PPA while patients with behavioural variant frontotempor
287  memory in a discussion of logopenic variant PPA, and components of language associated with discours
288 ent variant PPA (nfvPPA), 6 semantic variant PPA (svPPA) and 25 patients with subjective cognitive im
289  meaning in a discussion of semantic variant PPA, grammatical comprehension and expression in a discu
290 ary progressive aphasia and semantic variant PPA.
291                                   SPA versus PPA changes were significant at the SZ and TZ (T1), TZ a
292 ges in the entire sample depth of SPA versus PPA were found for delta1/2 (T1rho, 14% +/- 12 vs 6% +/-
293 gest a tripartite division of labor, whereby PPA codes landmark identity, RSC retrieves spatial or co
294                       Then we tested whether PPA is selectively activated by rectangular features in
295  on decreasing antibiotic DOTs compared with PPA.
296 s (4 women, 2 men) clinically diagnosed with PPA (3 with nfvPPA and 3 with lvPPA) in whom MRI and SPE
297 owed reduced scene-selective activity within PPA compared with healthy matched controls.
298 duces the level of selective activity within PPA, which may lead to related perceptual impairments in
299 he generation of "selective" activity within PPA.
300 f VCSL disruption on neural processes within PPA, HD patients showed reduced scene-selective activity
301              Disc, alpha-zone, and beta-zone PPA were traced independently by 2 trained readers and t

 
Page Top